Items of recent pandemic news you may have missed: What the delta variant actually does (hint: it doesn’t “transmit” better); about correlates of protection; and the unresolved question of how the J&J vaccine works against delta. Plus a frippery. J&J … Continue reading →
Items of recent pandemic news you may have missed: The animals sold in Wuhan’s wet markets; animal reservoirs for SARS-CoV-2; and animal vaccinations. Plus the usual frippery, this one animal-themed as well. A vaccine for zoo animals We have discussed … Continue reading →
Two items of recent pandemic news: The FDA says myocarditis is a rare side effect of mRNA vaccines; and a scientist recovers early Wuhan genetic sequences that went missing last year for unknown reasons. Plus news briefs and a frippery. … Continue reading →
Two items of recent pandemic news: Billions to develop antivirals that can be taken by mouth; and a hard fail in a vaccine Phase III trial. Plus news briefs and a frippery. CureVac falls flat You may have heard by … Continue reading →
Three items of recent pandemic news: the seriousness of the Delta variant; how a bitter taste might predict the severity of a Covid-19 outcome; and results from the Novavax Phase III trial. Plus news briefs and a frippery. Novavax results … Continue reading →
Items of recent pandemic news: Moderna applies to the FDA for full licensure; Minnesota and the Twin Cities end mask mandates; and cautious optimism that the pandemic is ending in the US. Plus news briefs and a brace of fripperies. … Continue reading →
Two items of recent pandemic news: Studies point to long-lasting, possibly lifelong immunity from natural infection; and rapid developments in the highly political question of where SARS-CoV-2 came from. Plus news briefs and a pair of fripperies. Origin, again It … Continue reading →
Three items of recent pandemic news: Pfizer’s vaccine can keep for 30 days at refrigerator temperatures; neutralizing antibody levels emerge as a correlate of protection; and the long stretch of post-trauma grief that awaits us. Plus news briefs and a … Continue reading →
Two items of recent pandemic news: Sanofi & GSK get some good news from a Phase II study of their reformulated vaccine candidate; and questions swirl anew around the origins of the pandemic virus. Plus news briefs and a frippery. … Continue reading →
Herewith three items of recent pandemic news: The toll of long Covid; Johnson & Johnson has no vaccine to ship; and the CDC’s unexpected new guidance on mask use in the vaccinated. Plus news briefs and a frippery. The CDC … Continue reading →
Herewith three items of recent pandemic news: More studies on mixing vaccine doses; the FDA extends Pfizer’s authorization to ages 12+; and acknowledgement from the CDC that this virus is airborne. Plus news briefs and a frippery. It is indeed … Continue reading →
Four items of recent pandemic news: Pfizer applies for full FDA approval; Moderna’s booster testing; the CDC’s optimistic report; and what it means that the US is open to waiving vaccine patent rights. Plus news briefs and a frippery. Waiving … Continue reading →
Belatedly, three items of recent pandemic news: Novavax and the EU; a detailed study of long haulers in the VA health care system; and the imminent authorization of Pfizer’s vaccine for young adolescents. Plus news briefs and a frippery. Authorization … Continue reading →
Herewith three items of pandemic news you may have missed recently: Disparate theories of long Covid; Europe locks in 1.8 billion Pfizer doses; and the troubles attendant upon Russia’s Sputnik V vaccine. Plus news briefs and a frippery. Russia’s Sputnik … Continue reading →
Three items of pandemic news you may have missed recently: Post-vaccination breakthrough infections are less than 0.008%; researchers estimate how much virus an infection produces; and an advisory committee punts on J&J. Plus news briefs and a frippery. Advisory committee … Continue reading →
